外用胰岛素治疗眼表疾病的研究进展
Research Advances on Topical Insulin Treatment for Eye Surface Diseases
DOI: 10.12677/acm.2024.1492456, PDF,   
作者: 占学军:团风县人民医院药学部,湖北 黄冈
关键词: 眼表疾病胰岛素角膜Eye Surface Diseases Insulin Cornea
摘要: 眼表疾病,包括干眼、角膜上皮缺损、神经营养性角膜病变、糖尿病角膜病变等,严重威胁患者的视力,影响患者的生活质量。胰岛素是一种多功能的生长因子,主要用于调节血糖,而局部胰岛素作为一种经济实惠的治疗方法,近年来研究发现其能够促进角膜伤口愈合、抑制炎症反应并保护角膜神经,有效改善眼表疾病的治疗现状。本文综述了外用胰岛素在眼表疾病治疗中的研究进展,从实验研究到临床试验探讨其治疗潜能和机制,分析了外用胰岛素治疗眼表疾病的剂型,阐释其疗效评估和安全性监测。
Abstract: Eye surface diseases seriously threaten vision of patients and affect their quality of life, including dry eye diseases, corneal epithelial defects, neurotrophic keratopathy, and diabetic keratopathy. Insulin, a multifunctional growth factor primarily used to regulate the level of blood glucose, has emerged as an effective and economical treatment in recent years. Extensive studies suggest that insulin is able to promote corneal wound healing, suppress inflammatory responses, and protect corneal nerves, thereby improving the treatment of eye surface diseases. This review summarizes the research progress of topical insulin in the treatment of eye surface diseases, discussing its therapeutic potential and mechanisms from experimental studies to clinical trials. Moreover, the review analyzes the formulations of topical insulin for treating eye surface diseases, elucidating its efficacy evaluation and safety monitoring.
文章引用:占学军. 外用胰岛素治疗眼表疾病的研究进展[J]. 临床医学进展, 2024, 14(9): 257-264. https://doi.org/10.12677/acm.2024.1492456

参考文献

[1] Norton, L., Shannon, C., Gastaldelli, A. and DeFronzo, R.A. (2022) Insulin: The Master Regulator of Glucose Metabolism. Metabolism, 129, Article 155142. [Google Scholar] [CrossRef] [PubMed]
[2] Greenway, S.E., Filler, L.E. and Greenway, F.L. (1999) Topical Insulin in Wound Healing: A Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Wound Care, 8, 526-528. [Google Scholar] [CrossRef] [PubMed]
[3] Emanuelli, T., Burgeiro, A. and Carvalho, E. (2016) Effects of Insulin on the Skin: Possible Healing Benefits for Diabetic Foot Ulcers. Archives of Dermatological Research, 308, 677-694. [Google Scholar] [CrossRef] [PubMed]
[4] Azevedo, F.F., Moreira, G.V., Teixeira, C.J., Pessoa, A.F.M., Alves, M.J., Liberti, E.A., et al. (2019) Topical Insulin Modulates Inflammatory and Proliferative Phases of Burn-Wound Healing in Diabetes-Induced Rats. Biological Research for Nursing, 21, 473-484. [Google Scholar] [CrossRef] [PubMed]
[5] Liu, Y., Dhall, S., Castro, A., Chan, A., Alamat, R. and Martins-Green, M. (2017) Insulin Regulates Multiple Signaling Pathways Leading to Monocyte/Macrophage Chemotaxis into the Wound Tissue. Biology Open, 7, bio026187. [Google Scholar] [CrossRef] [PubMed]
[6] Kakanj, P., Moussian, B., Grönke, S., Bustos, V., Eming, S.A., Partridge, L., et al. (2016) Insulin and TOR Signal in Parallel through FOXO and S6K to Promote Epithelial Wound Healing. Nature Communications, 7, Article No. 12972. [Google Scholar] [CrossRef] [PubMed]
[7] Apolinário, P.P., Zanchetta, F.C., Breder, J.S.C., Adams, G., Consonni, S.R., Gillis, R., et al. (2023) Anti-Inflammatory, Procollagen, and Wound Repair Properties of Topical Insulin Gel. Brazilian Journal of Medical and Biological Research, 56, e12640. [Google Scholar] [CrossRef] [PubMed]
[8] Castro Mora, M.P., Palacio Varona, J., Perez Riaño, B., Laverde Cubides, C. and Rey-Rodriguez, D.V. (2023) Effectiveness of Topical Insulin for the Treatment of Surface Corneal Pathologies. Archivos de la Sociedad Española de Oftalmología, 98, 220-232. [Google Scholar] [CrossRef] [PubMed]
[9] Park, R.B., Jain, S., Han, H. and Park, J. (2021) Ocular Surface Disease Associated with Immune Checkpoint Inhibitor Therapy. The Ocular Surface, 20, 115-129. [Google Scholar] [CrossRef] [PubMed]
[10] Mohamed, H.B., Abd El-Hamid, B.N., Fathalla, D. and Fouad, E.A. (2022) Current Trends in Pharmaceutical Treatment of Dry Eye Disease: A Review. European Journal of Pharmaceutical Sciences, 175, Articlre 106206. [Google Scholar] [CrossRef] [PubMed]
[11] Dua, H.S., Said, D.G., Messmer, E.M., Rolando, M., Benitez-del-Castillo, J.M., Hossain, P.N., et al. (2018) Neurotrophic Keratopathy. Progress in Retinal and Eye Research, 66, 107-131. [Google Scholar] [CrossRef] [PubMed]
[12] Priyadarsini, S., Whelchel, A., Nicholas, S., Sharif, R., Riaz, K. and Karamichos, D. (2020) Diabetic Keratopathy: Insights and Challenges. Survey of Ophthalmology, 65, 513-529. [Google Scholar] [CrossRef] [PubMed]
[13] Dogru, M., Okada, N., Asano-Kato, N., Tanaka, M., Igarashi, A., Takano, Y., et al. (2005) Atopic Ocular Surface Disease. Cornea, 24, S18-S23. [Google Scholar] [CrossRef] [PubMed]
[14] Zhang, X., Zhao, L., Deng, S., Sun, X. and Wang, N. (2016) Dry Eye Syndrome in Patients with Diabetes Mellitus: Prevalence, Etiology, and Clinical Characteristics. Journal of Ophthalmology, 2016, 1-7. [Google Scholar] [CrossRef] [PubMed]
[15] Rocha, E.M., Cunha, D.A., Carneiro, E.M., et al. (2002) Identification of Insulin in the Tear Film and Insulin Receptor and IGF-1 Receptor on the Human Ocular Surface. Investigative Ophthalmology & Visual Science, 43, 963-967.
[16] Peterson, C. and Chandler, H.L. (2022) Insulin Facilitates Corneal Wound Healing in the Diabetic Environment through the RTK-PI3K/Akt/mTOR Axis in Vitro. Molecular and Cellular Endocrinology, 548, Article 111611. [Google Scholar] [CrossRef] [PubMed]
[17] Shanley, L.J., McCaig, C.D., Forrester, J.V. and Zhao, M. (2004) Insulin, Not Leptin, Promotes in Vitro Cell Migration to Heal Monolayer Wounds in Human Corneal Epithelium. Investigative Opthalmology & Visual Science, 45, 1088-1094. [Google Scholar] [CrossRef] [PubMed]
[18] Yang, S., Zhang, Y., Zhang, Z., Dan, J., Zhou, Q., Wang, X., et al. (2020) Insulin Promotes Corneal Nerve Repair and Wound Healing in Type 1 Diabetic Mice by Enhancing Wnt/β-Catenin Signaling. The American Journal of Pathology, 190, 2237-2250. [Google Scholar] [CrossRef] [PubMed]
[19] Ko, J., Yanai, R. and Nishida, T. (2009) IGF-1 Released by Corneal Epithelial Cells Induces Up-Regulation of N-Cadherin in Corneal Fibroblasts. Journal of Cellular Physiology, 221, 254-261. [Google Scholar] [CrossRef] [PubMed]
[20] Patel, R., Zhu, M. and Robertson, D.M. (2018) Shifting the IGF-Axis: An Age-Related Decline in Human Tear IGF-1 Correlates with Clinical Signs of Dry Eye. Growth Hormone & IGF Research, 40, 69-73. [Google Scholar] [CrossRef] [PubMed]
[21] Aynsley, T.R. (1945) The Use of Insulin in the Treatment of Corneal Ulcers. British Journal of Ophthalmology, 29, 361-363. [Google Scholar] [CrossRef] [PubMed]
[22] Bastion, M.L. and Ling, K.P. (2013) Topical Insulin for Healing of Diabetic Epithelial Defects? A Retrospective Review of Corneal Debridement during Vitreoretinal Surgery in Malaysian Patients. Medical Journal of Malaysia, 68, 208-216.
[23] NaPier, E., Camacho, M., McDevitt, T.F. and Sweeney, A.R. (2022) Neurotrophic Keratopathy: Current Challenges and Future Prospects. Annals of Medicine, 54, 666-673. [Google Scholar] [CrossRef] [PubMed]
[24] Vaidyanathan, U., Hopping, G.C., Liu, H.Y., et al. (2019) Persistent Corneal Epithelial Defects: A Review Article. Med Hypothesis Discov Innov Ophthalmol, 8, 163-176.
[25] Cruzat, A., Pavan-Langston, D. and Hamrah, P. (2010) In Vivo Confocal Microscopy of Corneal Nerves: Analysis and Clinical Correlation. Seminars in Ophthalmology, 25, 171-177. [Google Scholar] [CrossRef] [PubMed]
[26] Quiroz-Mendoza, J.L., García-Roa, M., Romero-Morales, V., Valera-Cornejo, D., Vázquez-Membrillo, M., Ramírez-Neria, P., et al. (2021) Clinical Trial of Topical Insulin and Sodium Hyaluronate in the Treatment of Epithelial Defects Produced by Intraoperative Corneal Epithelial Debridement during Pars Plana Vitrectomy in Diabetics. Revista Mexicana de Oftalmología, 95, 63-70. [Google Scholar] [CrossRef
[27] Fai, S., Ahem, A., Mustapha, M., et al. (2017) Randomized Controlled Trial of Topical Insulin for Healing Corneal Epi-thelial Defects Induced during Vitreoretinal Surgery in Diabetics. Asia-Pacific Journal of Ophthalmology, 6, 418-424.
[28] Zagon, I.S. (2007) Use of Topical Insulin to Normalize Corneal Epithelial Healing in Diabetes Mellitus. Archives of Ophthalmology, 125, 1082-1088. [Google Scholar] [CrossRef] [PubMed]
[29] Titone, R., Zhu, M. and Robertson, D.M. (2018) Insulin Mediates De Novo Nuclear Accumulation of the IGF-1/Insulin Hybrid Receptor in Corneal Epithelial Cells. Scientific Reports, 8, Article No. 4378. [Google Scholar] [CrossRef] [PubMed]
[30] Diaz-Valle, D., Burgos‐Blasco, B., Rego-Lorca, D., Puebla-Garcia, V., Perez-Garcia, P., Benitez-del-Castillo, J.M., et al. (2021) Comparison of the Efficacy of Topical Insulin with Autologous Serum Eye Drops in Persistent Epithelial Defects of the Cornea. Acta Ophthalmologica, 100, e912-e919. [Google Scholar] [CrossRef] [PubMed]
[31] Wang, A.L., Weinlander, E., Metcalf, B.M., Barney, N.P., Gamm, D.M., Nehls, S.M., et al. (2017) Use of Topical Insulin to Treat Refractory Neurotrophic Corneal Ulcers. Cornea, 36, 1426-1428. [Google Scholar] [CrossRef] [PubMed]
[32] Aniah Azmi, N. and Bastion, M.C. (2020) Short-Term Results of Trial of Topical Insulin for Treatment of Dry Eyes in Diabetics. Eye & Contact Lens: Science & Clinical Practice, 46, S25-S32. [Google Scholar] [CrossRef] [PubMed]
[33] Burgos-Blasco, B., Diaz-Valle, D., Rego-Lorca, D., Perez-Garcia, P., Puebla-Garcia, V., Fernandez-Vigo, J.I., et al. (2023) Topical Insulin, a Novel Corneal Epithelial Regeneration Agent in Dry Eye Disease. European Journal of Ophthalmology, 34, 719-725. [Google Scholar] [CrossRef] [PubMed]
[34] Nakamura, M., Kawahara, M., Nakata, K. and Nishida, T. (2003) Restoration of Corneal Epithelial Barrier Function and Wound Healing by Substance P and IGF-1 in Rats with Capsaicin-Induced Neurotrophic Keratopathy. Investigative Opthalmology & Visual Science, 44, 2937-2940. [Google Scholar] [CrossRef] [PubMed]
[35] Mayer, J.P., Zhang, F. and DiMarchi, R.D. (2007) Insulin Structure and Function. Peptide Science, 88, 687-713. [Google Scholar] [CrossRef] [PubMed]
[36] Balal, S., Din, N., Ashton, C. and Ahmad, S. (2022) Healing of Chemical Injury-Related Persistent Corneal Epithelial Defects with Topical Insulin. Cornea, 42, 1000-1004. [Google Scholar] [CrossRef] [PubMed]
[37] Krolo, I., Behaegel, J., Termote, K., de Bruyn, B., De Schepper, M., Oellerich, S., et al. (2024) The Role of Topical Insulin in Ocular Surface Restoration: A Review. Survey of Ophthalmology. [Google Scholar] [CrossRef] [PubMed]
[38] Wong, C.Y., Al-Salami, H. and Dass, C.R. (2018) Microparticles, Microcapsules and Microspheres: A Review of Recent Developments and Prospects for Oral Delivery of Insulin. International Journal of Pharmaceutics, 537, 223-244. [Google Scholar] [CrossRef] [PubMed]
[39] Bayrami, S., Chamani, M., JamaliMoghadamSiahkali, S., SeyedAlinaghi, S., Shirmard, L.R., Bayrami, S., et al. (2024) Preparation, Characterization and in Vitro Evaluation of Insulin-PHBV Nanoparticles/Alginate Hydrogel Composite System for Prolonged Delivery of Insulin. Journal of Pharmaceutical Sciences, 113, 2552-2559. [Google Scholar] [CrossRef] [PubMed]
[40] Voronova, A., Prieto, C., Pardo-Figuerez, M., Lagaron, J.M., Sanyal, A., Demir, B., et al. (2022) Photothermal Activatable Mucoadhesive Fiber Mats for On-Demand Delivery of Insulin via Buccal and Corneal Mucosa. ACS Applied Bio Materials, 5, 771-778. [Google Scholar] [CrossRef] [PubMed]
[41] Bartlett, J.D., Slusser, T.G., Turner-Henson, A., Singh, K.P., Atchison, J.A. and Pillion, D.J. (1994) Toxicity of Insulin Administered Chronically to Human Eye in Vivo. Journal of Ocular Pharmacology and Therapeutics, 10, 101-107. [Google Scholar] [CrossRef] [PubMed]
[42] Bartlett, J.D., Turner-Henson, A., Atchison, J.A., Woolley, T.W. and Pillion, D.J. (1994) Insulin Administration to the Eyes of Normoglycemic Human Volunteers. Journal of Ocular Pharmacology and Therapeutics, 10, 683-690. [Google Scholar] [CrossRef] [PubMed]